表紙
市場調查報告書

子宮頸癌檢驗的歐洲市場:檢驗類型 (子宮頸抹片、HPV DNA)、各國市場規模、受診者數的預測

Europe Cervical Cancer Diagnostics Market & Forecast, By Test Type (Pap smear & HPV DNA) & Countries

出版商 Renub Research 商品編碼 427204
出版日期 內容資訊 英文 163 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
子宮頸癌檢驗的歐洲市場:檢驗類型 (子宮頸抹片、HPV DNA)、各國市場規模、受診者數的預測 Europe Cervical Cancer Diagnostics Market & Forecast, By Test Type (Pap smear & HPV DNA) & Countries
出版日期: 2018年06月13日內容資訊: 英文 163 Pages
簡介

本報告提供歐洲的子宮頸癌檢驗的市場調查,歐洲整體及各主要國家的受診者數的變化與預測,市場規模的變化與預測,各檢驗種類的明細,市場佔有率,市場促進因素、阻礙要素分析等彙整資料。

第1章 摘要整理

第2章 歐洲的子宮頸癌檢驗 (篩檢) 受診者數、預測

第3章 歐洲的子宮頸癌檢驗 (篩檢) 市場、預測

  • 子宮頸抹片檢驗
  • HPV DNA檢驗

第4章 歐洲的子宮頸癌檢驗 (篩檢)的受診者&市場佔有率、預測

  • 受診者佔有率、預測
  • 市場佔有率、預測
  • 子宮頸抹片檢驗市場佔有率、預測
  • HPV DNA檢驗市場佔有率、預測

第5章 英國市場分析

  • 子宮頸癌檢驗的受診者數
    • 子宮頸抹片檢驗
    • HPV DNA檢驗
  • 子宮頸癌的死亡率
  • 子宮頸癌檢驗的市場分析、預測
    • 子宮頸癌檢驗
    • 子宮頸抹片檢驗
    • HPV DNA檢驗

第6章 法國市場分析

  • 子宮頸癌檢驗的受診者數
    • 子宮頸抹片檢驗
    • HPV DNA檢驗
  • 子宮頸癌的死亡率
  • 子宮頸癌檢驗的市場分析、預測
    • 子宮頸癌檢驗
    • 子宮頸抹片檢驗
    • HPV DNA檢驗

第7章 德國市場分析

  • 子宮頸癌檢驗的受診者數
    • 子宮頸抹片檢驗
    • HPV DNA檢驗
  • 子宮頸癌的死亡率
  • 子宮頸癌檢驗的市場分析、預測
    • 子宮頸癌檢驗
    • 子宮頸抹片檢驗
    • HPV DNA檢驗

第8章 義大利市場分析

  • 子宮頸癌檢驗的受診者數
    • 子宮頸抹片檢驗
    • HPV DNA檢驗
  • 子宮頸癌的死亡率
  • 子宮頸癌檢驗的市場分析、預測
    • 子宮頸癌檢驗
    • 子宮頸抹片檢驗
    • HPV DNA檢驗

第9章 西班牙市場分析

  • 子宮頸癌檢驗的受診者數
    • 子宮頸抹片檢驗
    • HPV DNA檢驗
  • 子宮頸癌的死亡率
  • 子宮頸癌檢驗的市場分析、預測
    • 子宮頸癌檢驗
    • 子宮頸抹片檢驗
    • HPV DNA檢驗

第10章 瑞典市場分析

  • 子宮頸癌檢驗的受診者數
    • 子宮頸抹片檢驗
    • HPV DNA檢驗
  • 子宮頸癌的死亡率
  • 子宮頸癌檢驗的市場分析、預測
    • 子宮頸癌檢驗
    • 子宮頸抹片檢驗
    • HPV DNA檢驗

第11章 瑞士市場分析

  • 子宮頸癌檢驗的受診者數
    • 子宮頸抹片檢驗
    • HPV DNA檢驗
  • 子宮頸癌的死亡率
  • 子宮頸癌檢驗的市場分析、預測
    • 子宮頸癌檢驗
    • 子宮頸抹片檢驗
    • HPV DNA檢驗

第12章 挪威市場分析

  • 子宮頸癌檢驗的受診者數
    • 子宮頸抹片檢驗
    • HPV DNA檢驗
  • 子宮頸癌的死亡率
  • 子宮頸癌檢驗的市場分析、預測
    • 子宮頸癌檢驗
    • 子宮頸抹片檢驗
    • HPV DNA檢驗

第13章 荷蘭市場分析

  • 子宮頸癌檢驗的受診者數
    • 子宮頸抹片檢驗
    • HPV DNA檢驗
  • 子宮頸癌的死亡率
  • 子宮頸癌檢驗的市場分析、預測
    • 子宮頸癌檢驗
    • 子宮頸抹片檢驗
    • HPV DNA檢驗

第14章 市場促進因素

  • 10代的性感染疾病罹患率的全球性上升
  • HPV感染患者的全球的增加

第15章 市場課題

  • 人類乳突病毒(HPV)疫苗計劃的全球性引進

圖表

目錄

Europe Cervical Cancer Test Market, Patients, By Screening Type (Pap Smear, HPV DNA) (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway, Netherlands) is 119 Page market research report with 115 Figures and 2 Tables published by Renub Research.

Cervical cancer is one of the most serious public health issues in Europe. Despite introduction of vaccination in 21 European countries, still more than 24 Thousand women have died from cervical cancer across all over Europe. Cervical cancer incidence rate in Europe was 10.6 per 100,000 women population. Germany, France and United Kingdom are top three dominating countries in the Europe cervical cancer market in 2015.

All the 9 countries in the report have been studied from 3 viewpoints.

Cervical Cancer Test Market, Population & Mortality

1. Cervical Cancer Test Population (2008-2020)

  • Pap Smear Test Population & Forecast
  • HPV DNA Test Population & Forecast

2. Cervical Cancer Mortality Population (2001-2011)

3. Cervical Cancer Test Market (2008-2020)

  • Pap Smear Test Market & Forecast
  • HPV DNA Test Market & Forecast

9 Countries studied in the report are as follows

  • 1. United Kingdom
  • 2. France
  • 3. Germany
  • 4. Italy
  • 5. Spain
  • 6. Sweden
  • 7. Switzerland
  • 8. Norway
  • 9. Netherlands

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 1000 paid databases.

Table of Contents

1. Executive Summary

2. Europe Cervical Cancer Test (Screening) Population & Forecast

3. Europe Cervical Cancer Test (Screening) Market & Forecast

  • 3.1 Europe Cervical Cancer Pap Smear Test (Screening) Market & Forecast
  • 3.2 Europe Cervical Cancer HPV DNA Test (Screening) Market & Forecast

4. Europe Cervical Cancer Test (Screening) Population Share, Market Share & Forecast

  • 4.1 Europe Cervical Cancer Test (Screening) Population Share & Forecast
  • 4.2 Europe Cervical Cancer Test (Screening) Market Share & Forecast
  • 4.3 Europe Cervical Cancer Pap Smear Test (Screening) Market Share & Forecast
  • 4.4 Europe Cervical Cancer HPV DNA Test (Screening) Market Share & Forecast

5. United Kingdom - Cervical Cancer Test Analysis

  • 5.1 United Kingdom Cervical Cancer Test (Screening) Population
    • 5.1.1 United Kingdom Cervical Cancer Pap Smear Test Population & Forecast
    • 5.1.2 United Kingdom Cervical Cancer HPV DNA Test Population & Forecast
  • 5.2 United Kingdom Cervical Cancer Deaths
  • 5.3 United Kingdom Cervical Cancer Test (Screening) Analysis
    • 5.3.1 United Kingdom Cervical Cancer Test Market & Forecast
    • 5.3.2 United Kingdom Pap Smear Test Market & Forecast
    • 5.3.3 United Kingdom HPV DNA Test Market & Forecast

6. France - Cervical Cancer Test Analysis

  • 6.1 France Cervical Cancer Test (Screening) Population
    • 6.1.1 France Cervical Cancer Pap Smear Test Population & Forecast
    • 6.1.2 France Cervical Cancer HPV DNA Test Population & Forecast
  • 6.2 France Cervical Cancer Mortality
  • 6.3 France Cervical Cancer Test (Screening) Analysis
    • 6.3.1 France Cervical Cancer Test Market & Forecast
    • 6.3.2 France Pap Smear Test Market & Forecast
    • 6.3.3 France HPV DNA Test Market & Forecast

7. Germany - Cervical Cancer Test Analysis

  • 7.1 Germany Cervical Cancer Test (Screening) Population
    • 7.1.1 Germany Cervical Cancer Pap Smear Test Population & Forecast
    • 7.1.2 Germany Cervical Cancer HPV DNA Test Population & Forecast
  • 7.2 Germany Cervical Cancer Mortality
  • 7.3 Germany Cervical Cancer Test (Screening) Market
    • 7.3.1 Germany Cervical Cancer Test Market & Forecast
    • 7.3.2 Germany Pap Smear Test Market & Forecast
    • 7.3.3 Germany HPV DNA Test Market & Forecast

8. Italy - Cervical Cancer Test Analysis

  • 8.1 Italy Cervical Cancer Test (Screening) Population
    • 8.1.1 Italy Cervical Cancer Pap Smear Test Population & Forecast
    • 8.1.2 Italy Cervical Cancer HPV DNA Test Population & Forecast
  • 8.2 Italy Cervical Cancer Mortality
  • 8.3 Italy Cervical Cancer Test (Screening) Market
    • 8.3.1 Italy Cervical Cancer Test Market & Forecast
    • 8.3.2 Italy Pap Smear Test Market & Forecast
    • 8.3.3 Italy HPV DNA Test Market & Forecast

9. Spain - Cervical Cancer Test Analysis

  • 9.1 Spain Cervical Cancer Test (Screening) Population
    • 9.1.1 Spain Cervical Cancer Pap Smear Test Population & Forecast
    • 9.1.2 Spain Cervical Cancer HPV DNA Test Population & Forecast
  • 9.2 Spain Cervical Cancer Mortality
  • 9.3 Spain Cervical Cancer Test (Screening) Market
    • 9.3.1 Spain Cervical Cancer Test Market & Forecast
    • 9.3.2 Spain Pap Smear Test Market & Forecast
    • 9.3.3 Spain HPV DNA Test Market & Forecast

10. Sweden - Cervical Cancer Test Analysis

  • 10.1 Sweden Cervical Cancer Test (Screening) Population
    • 10.1.1 Sweden Cervical Cancer Pap Smear Test Population & Forecast
    • 10.1.2 Sweden Cervical Cancer HPV DNA Test Population & Forecast
  • 10.2 Sweden Cervical Cancer Mortality
  • 10.3 Sweden Cervical Cancer Test (Screening) Market
    • 10.3.1 Sweden Cervical Cancer Test Market & Forecast
    • 10.3.2 Sweden Pap Smear Test Market & Forecast
    • 10.3.3 Sweden HPV DNA Test Market & Forecast

11. Switzerland - Cervical Cancer Test Analysis

  • 11.1 Switzerland Cervical Cancer Test (Screening) Population
    • 11.1.1 Switzerland Cervical Cancer Pap Smear Test Population & Forecast
    • 11.1.2 Switzerland Cervical Cancer HPV DNA Test Population & Forecast
  • 11.2 Switzerland Cervical Cancer Mortality
  • 11.3 Switzerland Cervical Cancer Test (Screening) Market
    • 11.3.1 Switzerland Cervical Cancer Test Market & Forecast
    • 11.3.2 Switzerland Pap smear Test Market & Forecast
    • 11.3.3 Switzerland HPV DNA Test Market & Forecast

12. Norway - Cervical Cancer Test Analysis

  • 12.1 Norway Cervical Cancer Test (Screening) Population
    • 12.1.1 Norway Cervical Cancer Pap Smear Test Population & Forecast
    • 12.1.2 Norway Cervical Cancer HPV DNA Test Population & Forecast
  • 12.2 Norway Cervical Cancer Mortality
  • 12.3 Norway Cervical Cancer Test (Screening) Market
    • 12.3.1 Norway Cervical Cancer Test Market & Forecast
    • 12.3.2 Norway Pap Smear Test Market & Forecast
    • 12.3.3 Norway HPV DNA Test Market & Forecast

13. Netherlands - Cervical Cancer Test Analysis

  • 13.1 Netherlands Cervical Cancer Test (Screening) Population
    • 13.1.1 Netherlands Cervical Cancer Pap Smear Test Population & Forecast
    • 13.1.2 Netherlands Cervical Cancer HPV DNA Test Population & Forecast
  • 13.2 Netherlands Cervical Cancer Mortality
  • 13.3 Netherlands Cervical Cancer Test (Screening) Market
    • 13.3.1 Netherlands Cervical Cancer Test Market & Forecast
    • 13.3.2 Netherlands Pap Smear Test Market & Forecast
    • 13.3.3 Netherlands HPV DNA Test Market & Forecast

14. Cervical Cancer Test Market Growth Drivers

  • 14.1 Rising Cases of Teenage Sexual Cases Globally
  • 14.2 Huge Prevalence of HPV Infected Patients Globally

15. Challenges in Cervical Cancer Test Market

  • 15.1 Introduction of HPV Vaccination Programs Globally

List of Figures

  • Figure 2 1: Europe - Cervical Cancer Test Population (Million), 2008 - 2015
  • Figure 2 2: Europe - Forecast for Cervical Cancer Test Population (Million), 2016 - 2020
  • Figure 3 1: Europe - Cervical Cancer Test Market (Million US$), 2008 - 2015
  • Figure 3 2: Europe - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
  • Figure 3 3: Europe - Cervical Cancer Pap Smear Test Market (Million US$), 2008 - 2015
  • Figure 3 4: Europe - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2016 - 2020
  • Figure 3 5: Europe - Cervical Cancer HPV DNA Test Market (Million US$), 2008 - 2015
  • Figure 3 6: Europe - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2016 - 2020
  • Figure 4 1: Europe - Cervical Cancer Test Population Share (Percent), 2008 - 2015
  • Figure 4 2: Europe - Forecast for Cervical Cancer Test Population Share (Percent), 2016 - 2020
  • Figure 4 3: Europe - Cervical Cancer Test Market Share (Percent), 2008 - 2015
  • Figure 4 4: Europe - Forecast for Cervical Cancer Test Market Share (Percent), 2016 - 2020
  • Figure 4 5: Europe - Cervical Cancer Pap Smear Test Market Share (Percent), 2008 - 2015
  • Figure 4 6: Europe - Forecast for Cervical Cancer Pap Smear Test Market Share (Percent), 2016 - 2020
  • Figure 4 7: Europe - Cervical Cancer HPV DNA Test Market Share (Percent), 2008 - 2015
  • Figure 4 8: Europe - Forecast for Cervical Cancer HPV DNA Test Market Share (Percent), 2016 - 2020
  • Figure 5 1: United Kingdom - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
  • Figure 5 2: United Kingdom - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
  • Figure 5 3: United Kingdom - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
  • Figure 5 4: United Kingdom - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 - 2020
  • Figure 5 5: United Kingdom - Cervical Cancer Deaths (Number), 2001 - 2011
  • Figure 5 6: United Kingdom - Cervical Cancer Test Market (Million US$), 2008 - 2015
  • Figure 5 7: United Kingdom - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
  • Figure 5 8: United Kingdom - Pap Smear Test Market (Million US$), 2008 - 2015
  • Figure 5 9: United Kingdom - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
  • Figure 5 10: United Kingdom - HPV DNA Test Market (Million US$), 2008 - 2015
  • Figure 5 11: United Kingdom - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
  • Figure 6 1: France - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
  • Figure 6 2: France - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
  • Figure 6 3: France - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
  • Figure 6 4: France - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 - 2020
  • Figure 6 5: France - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 6 6: France - Cervical Cancer Test Market (Million US$), 2008 - 2015
  • Figure 6 7: France - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
  • Figure 6 8: France - Pap Smear Test Market (Million US$), 2008 - 2015
  • Figure 6 9: France - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
  • Figure 6 10: France - HPV DNA Test Market (Million US$), 2008 - 2015
  • Figure 6 11: France - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
  • Figure 7 1: Germany - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
  • Figure 7 2: Germany - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
  • Figure 7 3: Germany - Cervical Cancer HPV DNA Test Population (Thousand), 2005 - 2013
  • Figure 7 4: Germany - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 - 2020
  • Figure 7 5: Germany - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 7 6: Germany - Cervical Cancer Test Market (Million US$), 2008 - 2015
  • Figure 7 7: Germany - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
  • Figure 7 8: Germany - Pap Smear Test Market (Million US$), 2008 - 2015
  • Figure 7 9: Germany - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
  • Figure 7 10: Germany - HPV DNA Test Market (Million US$), 2008 - 2015
  • Figure 7 11: Germany - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
  • Figure 8 1: Italy - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
  • Figure 8 2: Italy - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
  • Figure 8 3: Italy - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
  • Figure 8 4: Italy - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 - 2020
  • Figure 8 5: Italy - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 8 6: Italy - Cervical Cancer Test Market (Million US$), 2008 - 2015
  • Figure 8 7: Italy - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
  • Figure 8 8: Italy - Pap Smear Test Market (Million US$), 2008 - 2015
  • Figure 8 9: Italy - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
  • Figure 8 10: Italy - HPV DNA Test Market (Million US$), 2008 - 2015
  • Figure 8 11: Italy - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
  • Figure 9 1: Spain - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
  • Figure 9 2: Spain - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
  • Figure 9 3: Spain - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
  • Figure 9 4: Spain - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 -2020
  • Figure 9 5: Spain - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 9 6: Spain - Cervical Cancer Test Market (Million US$), 2008 - 2015
  • Figure 9 7: Spain - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
  • Figure 9 8: Spain - Pap Smear Test Market (Million US$), 2008 - 2015
  • Figure 9 9: Spain - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
  • Figure 9 10: Spain - HPV DNA Test Market (Million US$), 2008 - 2015
  • Figure 9 11: Spain - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
  • Figure 10 1: Sweden - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
  • Figure 10 2: Sweden - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
  • Figure 10 3: Sweden - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
  • Figure 10 4: Sweden - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 - 2020
  • Figure 10 5: Sweden - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 10 6: Sweden - Cervical Cancer Test Market (Million US$), 2008 - 2015
  • Figure 10 7: Sweden - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
  • Figure 10 8: Sweden - Pap Smear Test Market (Million US$), 2008 - 2015
  • Figure 10 9: Sweden - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
  • Figure 10 10: Sweden - HPV DNA Test Market (Million US$), 2008 - 2015
  • Figure 10 11: Sweden - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
  • Figure 11 1: Switzerland - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
  • Figure 11 2: Switzerland - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
  • Figure 11 3: Switzerland - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
  • Figure 11 4: Switzerland - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 - 2020
  • Figure 11 5: Switzerland - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 11 6: Switzerland - Cervical Cancer Test Market (Million US$), 2008 - 2015
  • Figure 11 7: Switzerland - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
  • Figure 11 8: Switzerland - Pap Smear Test Market (Million US$), 2008 - 2015
  • Figure 11 9: Switzerland - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
  • Figure 11 10: Switzerland - HPV DNA Test Market (Million US$), 2008 - 2015
  • Figure 11 11: Switzerland - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
  • Figure 12 1: Norway - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
  • Figure 12 2: Norway - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
  • Figure 12 3: Norway - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
  • Figure 12 4: Norway - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 - 2020
  • Figure 12 5: Norway - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 12 6: Norway - Cervical Cancer Test Market (Million US$), 2008 - 2015
  • Figure 12 7: Norway - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
  • Figure 12 8: Norway - Pap Smear Test Market (Million US$), 2008 - 2015
  • Figure 12 9: Norway - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
  • Figure 12 10: Norway - HPV DNA Test Market (Million US$), 2008 - 2015
  • Figure 12 11: Norway - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
  • Figure 13 1: Netherlands - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
  • Figure 13 2: Netherlands - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
  • Figure 13 3: Netherlands - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
  • Figure 13 4: Netherlands - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 - 2020
  • Figure 13 5: Netherlands - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 13 6: Netherlands - Cervical Cancer Test Market (Million US$), 2008 - 2015
  • Figure 13 7: Netherlands - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
  • Figure 13 8: Netherlands - Pap Smear Test Market (Million US$), 2008 - 2015
  • Figure 13 9: Netherlands - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
  • Figure 13 10: Netherlands - HPV DNA Test Market (Million US$), 2008 - 2015
  • Figure 13 11: Netherlands - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020

List of Tables

  • Table 25 3: Worldwide - Prevalence (Percent) of Young Women (15-44 Years) who Have Sex before the Age of 15 Years, 1994 - 2006
  • Table 25 4: Worldwide - HPV Prevalence (Percent) among Women with Normal Cervical Cytology, 2010
Back to Top